| Advantages | They undergo rigorous quality control to ensure high fidelity, scalability, and genetic stability, making them ideal for a wide range of biomedical research applications. |
| Species | Human |
| Product Type | iPSC-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Intestinal |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | These organoids closely mimic the structure and function of native intestinal tissue, exhibiting self-organizing properties and biological behaviors analogous to in vivo systems. These organoids contain multiple cell types, including intestinal epithelial cells, mesenchymal cells, enterocytes, Paneth cells, and goblet cells, forming crypt-like, villus-like, and microvillus-like structures. |
| Applications | iPSC-derived organoids find applications across multiple research domains, including disease modeling, drug discovery, gene therapy evaluation, and personalized medicine. They recapitulate diverse disease states, providing reliable platforms for studying neurodegenerative diseases, cancer, cardiovascular conditions, and other disorders. These organoids are also valuable for drug efficacy and safety testing, tissue regeneration studies, and exploring host-microbe interactions, advancing innovation in biomedical research. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.